ReLive is a pioneering global biotechnology company, founded in 2021 by a team of distinguished visionaries and accomplished experts in the fields of tissue engineering, regenerative medicine, and cell therapy.
Backed by venture capital, along with the acquisition of CO.DON, ReLive brings together a diverse team of scientists, surgeons, managers and regulatory experts with extensive and direct experience in biotechnology, to collaborate and develop groundbreaking treatments that improve patient outcomes.
Through our ongoing research and development efforts, we strive to make a lasting impact on the field of biotechnology and cell therapy and revolutionize the treatment of orthopedic and reconstructive conditions.
Company Details
- Employees
- 11
- Address
- Wyman St, Waltham,massachusetts 02451,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.relivebio.com
- HQ
- Waltham, Massachusetts
Relive Biotechnologies Limited Questions
Relive Biotechnologies Limited's website is http://www.relivebio.com
Relive Biotechnologies Limited's LinkedIn profile is https://www.linkedin.com/company/relive-biotechnologies-limited
Relive Biotechnologies Limited has
11 employees.
View email and phone details for 11
employees at Relive Biotechnologies Limited.
Relive Biotechnologies Limited's industry is
Biotechnology Research
Relive Biotechnologies Limited's top competitors are
Biopoly,
Hyalex Orthopaedics Inc.,
Co.don Gmbh,
Curiteva, Inc.,
Vericel® Corporation,
Nanochon,
Zkr Orthopedics,
Native Orthopaedics,
Regenity Biosciences,
Sparta Biomedical.
Relive Biotechnologies Limited's categories are Biotechnology Research
